Related Experiment Videos
Unsaturated fatty acids in the management of hyperlipidemias
G Crepaldi1, S Zambon, E Manzato
1Department of Internal Medicine, University of Padova, Italy.
World Review of Nutrition and Dietetics
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real-World Evidence in a Rapidly Evolving Therapeutic Landscape.
European journal of haematology·2026
Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing.
Mediterranean journal of hematology and infectious diseases·2025
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.
Journal of bone oncology·2025
Complete androgen insensitivity syndrome (CAIS) and eating disorders: a case report.
Eating and weight disorders : EWD·2020
Lipoprotein-X fifty years after its original discovery.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Orbital Septal Fascial Flap with Extensive Release of a Long Orbital Fat Flap for Correcting Lower Eyelid Bags Associated with Midface Depression.
Journal of visualized experiments : JoVE·2026
Adipose-derived microRNA-518a drives hepatic cholesterol dysregulation and hypertension-related vascular remodeling in metabolic dysfunction-associated steatohepatitis via the MST1-AMPK-SREBP2 axis.
Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Extracellular Vesicle Surface Protein Profiling in Metabolic Dysfunction-associated Steatotic Liver Disease in Obesity.
Journal of extracellular biology·2026
Prevalence and Associated Factors of Metabolic Dysfunction-Associated Steatotic Liver Disease Across Obesity Metabolic Phenotypes in Chronic Schizophrenia.
International journal of general medicine·2026
The association between BMI and cognition, disability, and quality of life markers in multiple sclerosis: DISCOMS secondary analysis.
Therapeutic advances in neurological disorders·2026